Review of Major Social Determinants of Health in Schizophrenia-Spectrum Psychotic Disorders: I. Clinical Outcomes.


Journal

Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760

Informations de publication

Date de publication:
04 07 2023
Historique:
pmc-release: 06 04 2024
medline: 6 7 2023
pubmed: 7 4 2023
entrez: 6 4 2023
Statut: ppublish

Résumé

Social determinants of health (SDoHs) are receiving growing attention and are particularly relevant to persons with schizophrenia-spectrum psychotic disorders (SSPDs), considering their heightened risk of comorbidities, cognitive and functional decline, and early mortality. Yet, we did not find any comprehensive review of multiple SDoHs in SSPD. We conducted a scoping review of meta-analyses and systematic reviews of nine major SDoHs in SSPD. Childhood abuse, parental psychopathology, parental communication problems, bullying, and urban settings with lower socioeconomic status were major risk factors for the greater incidence of SSPD and/or worse health. Social network size was inversely associated with overall psychopathology and negative symptoms. Experiences of racial/ethnic discrimination correlated with the prevalence of psychotic symptoms and experiences. Compared to native populations, the risk of psychosis was higher in immigrants, refugees, and asylees. Social fragmentation was associated with an increased prevalence of schizophrenia. Homeless populations had a 30-fold higher prevalence of schizophrenia than the general population. Seriously mentally ill people were 2.7 times more likely to report food insecurity than controls. The prevalence of non-affective psychosis in prisoners was 2.0%-6.5%, compared to 0.3% in the general population. Certain potentially positive factors like family and community resilience remain poorly studied. SDoHs are associated with higher rates of and worse outcomes in SSPD. Well-designed longitudinal studies are needed to understand SDoHs' contribution to health in persons with SSPD, to develop interventions, and to implement changes in clinical care and public health policies that would reduce adverse health impacts of SDoHs. Positive SDoHs deserve greater attention.

Sections du résumé

BACKGROUND
Social determinants of health (SDoHs) are receiving growing attention and are particularly relevant to persons with schizophrenia-spectrum psychotic disorders (SSPDs), considering their heightened risk of comorbidities, cognitive and functional decline, and early mortality. Yet, we did not find any comprehensive review of multiple SDoHs in SSPD.
STUDY DESIGN
We conducted a scoping review of meta-analyses and systematic reviews of nine major SDoHs in SSPD.
STUDY RESULTS
Childhood abuse, parental psychopathology, parental communication problems, bullying, and urban settings with lower socioeconomic status were major risk factors for the greater incidence of SSPD and/or worse health. Social network size was inversely associated with overall psychopathology and negative symptoms. Experiences of racial/ethnic discrimination correlated with the prevalence of psychotic symptoms and experiences. Compared to native populations, the risk of psychosis was higher in immigrants, refugees, and asylees. Social fragmentation was associated with an increased prevalence of schizophrenia. Homeless populations had a 30-fold higher prevalence of schizophrenia than the general population. Seriously mentally ill people were 2.7 times more likely to report food insecurity than controls. The prevalence of non-affective psychosis in prisoners was 2.0%-6.5%, compared to 0.3% in the general population. Certain potentially positive factors like family and community resilience remain poorly studied.
CONCLUSIONS
SDoHs are associated with higher rates of and worse outcomes in SSPD. Well-designed longitudinal studies are needed to understand SDoHs' contribution to health in persons with SSPD, to develop interventions, and to implement changes in clinical care and public health policies that would reduce adverse health impacts of SDoHs. Positive SDoHs deserve greater attention.

Identifiants

pubmed: 37022779
pii: 7109996
doi: 10.1093/schbul/sbad023
pmc: PMC10318890
doi:

Types de publication

Review Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

837-850

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH121546
Pays : United States
Organisme : NIMH NIH HHS
ID : R01MH120201
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH019934
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Am J Psychiatry. 2021 Jul;178(7):599-610
pubmed: 33934608
Int J Prison Health. 2017 Sep 11;13(3-4):168-172
pubmed: 28914124
Psychiatr Serv. 2019 Nov 1;70(11):975
pubmed: 31672109
Soc Psychiatry Psychiatr Epidemiol. 2018 Sep;53(9):873-888
pubmed: 29951929
Health Aff (Millwood). 2018 Apr;37(4):585-590
pubmed: 29608369
Psychol Med. 2020 May;50(7):1077-1089
pubmed: 32317042
Schizophr Res. 2017 Dec;190:82-87
pubmed: 28318842
Lancet Psychiatry. 2020 May;7(5):399-410
pubmed: 32220288
J Clin Psychiatry. 2015 May;76(5):554-61
pubmed: 25938474
Annu Rev Public Health. 2011;32:381-98
pubmed: 21091195
Psychiatr Serv. 2020 Apr 1;71(4):355-363
pubmed: 31795858
Schizophr Res. 2018 Jun;196:9-13
pubmed: 28964652
Psychiatr Serv. 2014 Jul;65(7):862-72
pubmed: 24686574
Curr Psychiatry Rep. 2018 Sep 17;20(11):95
pubmed: 30221308
Psychiatry Res. 2016 Jul 30;241:309-14
pubmed: 27232552
BMC Public Health. 2021 Nov 18;21(1):2118
pubmed: 34794401
J Clin Psychiatry. 2023 Jan 16;84(2):
pubmed: 36652687
Am J Health Promot. 2020 Feb;34(2):215-219
pubmed: 31931601
Early Interv Psychiatry. 2014 Feb;8(1):77-81
pubmed: 23773288
World Psychiatry. 2016 Jun;15(2):93-102
pubmed: 27265690
JAMA Psychiatry. 2019 Nov 1;76(11):1133-1140
pubmed: 31411649
J Clin Psychiatry. 2021 Dec 7;83(1):
pubmed: 34875149
Lancet. 2005 Mar 19-25;365(9464):1099-104
pubmed: 15781105
Focus (Am Psychiatr Publ). 2020 Jan;18(1):75-76
pubmed: 32015731
PLoS One. 2022 Oct 13;17(10):e0275004
pubmed: 36228007
Int J Epidemiol. 2017 Aug 1;46(4):1157-1170
pubmed: 28338900
Schizophr Bull. 2018 Oct 17;44(6):1275-1292
pubmed: 29206972
Annu Rev Public Health. 2019 Apr 1;40:105-125
pubmed: 30601726
Health Promot Int. 2022 Jun 1;37(3):
pubmed: 35788299
Focus (Am Psychiatr Publ). 2020 Jan;18(1):25-30
pubmed: 32047394
Crit Rev Food Sci Nutr. 2021 Nov 16;:1-18
pubmed: 34783286
PLoS One. 2014 Jun 16;9(6):e99154
pubmed: 24932679
Am J Epidemiol. 2016 May 15;183(10):902-10
pubmed: 27026337
Br J Psychiatry. 2012 May;200(5):364-73
pubmed: 22550330
Am J Geriatr Psychiatry. 2016 Dec;24(12):1158-1170
pubmed: 27742528
Health Place. 2009 Sep;15(3):670-8
pubmed: 19117792
PLoS Med. 2021 Aug 23;18(8):e1003750
pubmed: 34424908
BMC Psychiatry. 2019 Nov 27;19(1):370
pubmed: 31775786
Soc Sci Med. 2013 Nov;97:325-30
pubmed: 23557675
Public Health Rep. 2014 Jan-Feb;129 Suppl 2:19-31
pubmed: 24385661
Bull World Health Organ. 2019 Jun 1;97(6):436-437
pubmed: 31210682
JAMA Psychiatry. 2022 Apr 1;79(4):283-284
pubmed: 35195678
Trop Med Int Health. 2020 Apr;25(4):414-423
pubmed: 31925844
Curr Opin Psychol. 2022 Feb;43:232-237
pubmed: 34438331
Psychiatry Res. 2020 Nov;293:113374
pubmed: 32795771
BMC Public Health. 2020 Jun 8;20(1):879
pubmed: 32513215
Am J Community Psychol. 2020 Sep;66(1-2):201-213
pubmed: 32153031
Soc Psychiatry Psychiatr Epidemiol. 2019 Nov;54(11):1311-1323
pubmed: 31482194
Schizophr Bull. 2017 Mar 1;43(2):227-229
pubmed: 28399307
Lancet Glob Health. 2019 Apr;7(4):e461-e471
pubmed: 30879509
Front Public Health. 2019 Feb 08;7:11
pubmed: 30800646
CNS Spectr. 2020 Oct;25(5):659-666
pubmed: 32195644
Am J Psychiatry. 2023 Feb 1;180(2):108-110
pubmed: 36722124
Psychol Med. 2018 Oct;48(13):2101-2115
pubmed: 29467052
Psychiatry Res. 2018 Oct;268:15-20
pubmed: 29986172
Eur Arch Psychiatry Clin Neurosci. 2020 Apr;270(3):325-335
pubmed: 31161262
Indian J Psychiatry. 2017 Oct-Dec;59(4):442-450
pubmed: 29497186
Am J Psychiatry. 2003 Dec;160(12):2202-8
pubmed: 14638591
Schizophr Res. 2022 May;243:247-253
pubmed: 32229262
Scand J Public Health. 2020 Jul;48(5):473-479
pubmed: 32009587
World J Psychiatry. 2014 Dec 22;4(4):133-40
pubmed: 25540728
J Fam Psychol. 2015 Dec;29(6):945-51
pubmed: 26168262
Am J Public Health. 2022 Apr;112(4):624-632
pubmed: 35319958
Lancet. 2008 Nov 8;372(9650):1661-9
pubmed: 18994664
Am J Public Health. 2014 Sep;104 Suppl 4:S517-9
pubmed: 25100411
J Acad Nutr Diet. 2022 Oct;122(10S):S12-S19
pubmed: 36122954
Lancet Psychiatry. 2018 Apr;5(4):357-369
pubmed: 29580610
Am J Psychiatry. 2004 Aug;161(8):1490-3
pubmed: 15285980
Brain Sci. 2016 Jul 27;6(3):
pubmed: 27472366
Am J Public Health. 2019 Jan;109(S1):S70-S71
pubmed: 30699027
World Psychiatry. 2018 Feb;17(1):49-66
pubmed: 29352556
J Fam Psychol. 2018 Jun;32(4):507-516
pubmed: 29389150
J Am Med Inform Assoc. 2020 Nov 1;27(11):1764-1773
pubmed: 33202021
Schizophr Bull. 2010 Jul;36(4):655-64
pubmed: 20513653
Front Psychiatry. 2021 Oct 22;12:665957
pubmed: 34744806
Psychiatr Serv. 2007 Dec;58(12):1577-81
pubmed: 18048559
Front Psychiatry. 2016 Dec 19;7:202
pubmed: 28066275
Psychiatr Serv. 2004 Nov;55(11):1285-93
pubmed: 15534018
Scand J Caring Sci. 2021 Jun;35(2):642-649
pubmed: 32628789
Early Interv Psychiatry. 2021 Feb;15(1):96-103
pubmed: 31943807
Aging Ment Health. 2018 Mar;22(3):354-362
pubmed: 27834490
Br J Psychiatry. 2014 Aug;205(2):88-94
pubmed: 25252316

Auteurs

Dylan J Jester (DJ)

Department of Psychiatry, University of California, San Diego, CA, USA.

Michael L Thomas (ML)

Department of Psychology, Colorado State University, Fort Collins, CO, USA.

Emily T Sturm (ET)

Department of Psychology, Colorado State University, Fort Collins, CO, USA.

Philip D Harvey (PD)

Department of Psychiatry, University of Miami Miller School of Medicine, and Research Service, Bruce W. Carter Miami VA Medical Center, Miami, FL, USA.

Matcheri Keshavan (M)

Department of Psychiatry, Beth Israel Deaconess medical Center and Harvard Medical School, Boston, MA, USA.

Beshaun J Davis (BJ)

Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.

Shekhar Saxena (S)

Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA.

Rajesh Tampi (R)

Department of Psychiatry, Creighton University School of Medicine, Omaha, NE, USA.

Heather Leutwyler (H)

Department of Physiological Nursing, University of California, San Francisco, CA, USA.

Michael T Compton (MT)

Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA.

Barton W Palmer (BW)

Department of Psychiatry, University of California, San Diego, CA, USA.
Veterans Affairs San Diego Healthcare System, Mental Illness Research, Education, and Clinical Center, San Diego, CA, USA.

Dilip V Jeste (DV)

Department of Psychiatry, University of California, San Diego, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH